BioHealth News Archive

Science in the City – UM BioPark

Science in the City – UM BioPark

Host:  UM BioPark & Wexford + Technology Location:  UM BioPark Life Sciences Conference Center 801 W. Baltimore Street Baltimore  Maryland  21201 Time:  5:00pm to 6:30pm Please…

Read More
State Funding Gives Sharp Boost to NJ’s Biotech, Life Sciences Industry – NJ Spotlight

State Funding Gives Sharp Boost to NJ’s Biotech, Life Sciences Industry – NJ Spotlight

A record number of biotechnology, life sciences and other tech-related companies with a presence in New Jersey stand to benefit from private investments spurred…

Read More
Starting a Medtech Company? Try Skipping Venture Capital, VCs Say – Xconomy

Starting a Medtech Company? Try Skipping Venture Capital, VCs Say – Xconomy

What’s the best way to build a startup? Bootstrap it, raise little or no VC funding, and (ideally) sell it for hundreds of millions—or…

Read More
Gaithersburg’s NexImmune acquired by investor consortium of Teva Pharmaceuticals , Celgene Corp. , Medtronic alums – Washington Business Journal

Gaithersburg’s NexImmune acquired by investor consortium of Teva Pharmaceuticals , Celgene Corp. , Medtronic alums – Washington Business Journal

Gaithersburg-based NexImmune, a biotech developing immunotherapy treatments for cancer, has been acquired by a consortium of big-name biotech veterans and investors. {iframe}http://www.bizjournals.com/washington/news/2017/02/14/roivant-sciences.html{/iframe}

Read More
THE ROOTS OF INNOVATION -U.S. Chamber International IP Index

THE ROOTS OF INNOVATION -U.S. Chamber International IP Index

Welcome to the fifth edition of the U.S. Chamber International IP Index, “The Roots of Innovation.” This year’s index recognizes the indispensable role of…

Read More
Baltimore CONNECTpreneur Feb 28, and CALL FOR PRESENTERS for Bethesda CONNECTpreneur on April 4

Baltimore CONNECTpreneur Feb 28, and CALL FOR PRESENTERS for Bethesda CONNECTpreneur on April 4

The Big Idea CONNECTpreneur Forum is a Community of over 5000 CEOs, Entrepreneurs, VCs and angels, CXOs and other business leaders in the Mid-Atlantic…

Read More
Illumina Accelerator Welcomes its Fifth Cycle of Genomic Startups

Illumina Accelerator Welcomes its Fifth Cycle of Genomic Startups

Illumina Accelerator, the genomics-based company creation engine focused on building early stage genomics startups welcomes three new companies to its fifth funding cycle. Since…

Read More

2017 BioHealth Capital Region Forum

Join us as we showcase accomplishments and discuss opportunities for the future of the BioHealth industry in the BioHealth Capital Region. This invitation-only event…

Read More
Startup Professionals Musings: 13 Red Flags To Avoid In Your Investor Funding Pitch

Startup Professionals Musings: 13 Red Flags To Avoid In Your Investor Funding Pitch

After listening to hundreds of startup pitches, and reading even more business plans, most new venture investors develop their own favorite list of “red…

Read More
Organization for rare diseases India (ORDI) – addressing the challenges and opportunities for the Indian rare diseases’ community | Genetics Research | Cambridge Core

Organization for rare diseases India (ORDI) – addressing the challenges and opportunities for the Indian rare diseases’ community | Genetics Research | Cambridge Core

In order to address the unmet needs and create opportunities that benefit patients with rare disease in India, a group of volunteers created a…

Read More
Elon Musk: Humans Need to Merge With Machines to Remain Relevant – Fortune.com

Elon Musk: Humans Need to Merge With Machines to Remain Relevant – Fortune.com

Tesla and SpaceX founder Elon Musk has a suggestion for humans who want to stay relevant in a future of artificial intelligence: merge with…

Read More
Top 10 Brilliant Ideas and Stupid Mistakes: Secrets of Phase II Proposal Success

Top 10 Brilliant Ideas and Stupid Mistakes: Secrets of Phase II Proposal Success

Last month, we outlined our top 10 do's and don'ts for getting your Phase I NIH proposal in shape and ready to submit before…

Read More
Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program

Orgenesis Approved for Euro 12.3 Million European Grant for Further Development of Its Type 1 Diabetes Program

Orgenesis Inc. (OTCQB: ORGS), a fully-integrated cell therapy and contract development and manufacturing company, announced that its Belgian subsidiary, Orgenesis SPRL, has received the…

Read More
This Technology Could Finally Make Brain Implants Practical

This Technology Could Finally Make Brain Implants Practical

In labs testing how brain implants could help people with physical disabilities, tales of success can be bittersweet. Experiments like those that let a…

Read More
Maryland: The state of research – Maryland Daily Record

Maryland: The state of research – Maryland Daily Record

Which state has the nation’s most research-intensive economy? California? Massachusetts? North Carolina? Actually it’s Maryland. A greater portion of Maryland’s economy comes from private,…

Read More